152609-83-1

Basic information

• Product Name: 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5-(phenylmethoxy)phenoxy]propoxy]phenoxy]-benzoic acid methyl ester
• Synonyms: 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5-(phenylmethoxy)phenoxy]propoxy]phenoxy]-benzoic acid methyl ester
• CAS NO: 152609-83-1
• Molecular Weight: 648.771
• Mol File: 152609-83-1.mol
• Article Data: 10

Chemical Properties

• CAS DataBase Reference: 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5-(phenylmethoxy)phenoxy]propoxy]phenoxy]-benzoic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5-(phenylmethoxy)phenoxy]propoxy]phenoxy]-benzoic acid methyl ester(152609-83-1)
• EPA Substance Registry System: 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5-(phenylmethoxy)phenoxy]propoxy]phenoxy]-benzoic acid methyl ester(152609-83-1)

Safety Data

• Hazardous Substances Data: 152609-83-1(Hazardous Substances Data)

Upstream product

• 152120-11-1 4-(benzyloxy)-5-(4-fluorophenyl)-2-(3-iodopropoxy)ethylbenzene 
• 152609-76-2 2-(3-hydroxy-2-propylphenoxy)-benzoic acid methyl ester 
• 152120-07-5 2-benzyloxy-1-(4-fluorophenyl)-5-ethyl-4-(3-chloro-1-propyloxy)benzene 
• 152609-60-4 1-bromo-2-(phenylmethoxy)-4-[(3-chloropropyl)oxy]-5-ethylbenzene 
• 152609-58-0 4-(benzyloxy)-2-(3-chloropropoxy)acetophenone 
• 152609-59-1 1-benzyloxy-4-ethyl-3-(3-chloro-1-propyloxy)-benzene 
• 93114-94-4 3-methoxy-2-propylphenol 
• 16929-64-9 1,3-Dimethoxy-2-(prop-1'-yl)benzene 
• 13331-19-6 2-propyl-1,3-benzenediol 
• 29682-12-0 1-[4-(benzyloxy)-2-hydroxyphenyl]ethanone 
• 151-10-0 1,3-Dimethoxybenzene 
• 171880-02-7 2-(3-methoxy-2-propylphenoxy)benzonitrile 
• 676155-38-7 2-(3-Hydroxy-2-propyl-phenoxy)-benzoic acid 
• 152609-78-4 3-(2-cyanophenoxy)2-propylphenol 

Downstream Products

• 161172-51-6 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5-hydroxyphenoxy]propoxy]phenoxy]benzoic acid 

Relevant articles and documents

Methods for identifying and treating resistant tumors

This invention provides a method of identifying and reversing multidrug resistance in a multidrug resistance tumor comprising administering a multidrug resistance reversing amount of any of the compounds as defined herein.

LEUKOTRIENE ANTAGONISTS USEFUL FOR TREATING DERMATOSES

This invention provides methods for the treatment or inhibiting of dermatitis which comprises administering to a mammal in need thereof an effective amount of a compound having activity as a leukotriene B 4 antagonist.

LEUKOTRIENE ANTAGONISTS FOR USE IN THE TREATMENT OR INHIBITION OF CEREBRAL FOCAL STROKE

This invention provides methods for the treatment or prevention of cerebral focal ischemia which comprises administering to a mammal in need thereof an effective amount of a compound having activity as a leukotriene B 4 antagonist.